These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26153258)

  • 1. How to differentiate the etiology of LV dysfunction as to whether it is "ischemic cardiomyopathy" or "dilated non-ischemic cardiomyopathy"? Invasive coronary and myocardial assessment is the approach of first choice.
    Ahn SG; Samady H
    J Nucl Cardiol; 2015 Oct; 22(5):953-6. PubMed ID: 26153258
    [No Abstract]   [Full Text] [Related]  

  • 2. Debates: Introduction.
    Iskandrian AE
    J Nucl Cardiol; 2015 Oct; 22(5):952. PubMed ID: 26153259
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluating left ventricular systolic dysfunction: Stress echocardiography.
    Argulian E; Chaudhry FA
    J Nucl Cardiol; 2015 Oct; 22(5):957-60. PubMed ID: 26153256
    [No Abstract]   [Full Text] [Related]  

  • 4. Adenosine Tc-99m tetrofosmin SPECT in differentiation of ischemic from nonischemic cardiomyopathy in patients with LV systolic dysfunction.
    Her SH; Yoon HJ; Lee JM; Jin SW; Youn HJ; Seung KB; Kim JH
    Clin Nucl Med; 2008 Jul; 33(7):459-63. PubMed ID: 18580229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early detection and significance of structural cardiovascular abnormalities in patients with Type 2 diabetes mellitus.
    Somaratne JB; Whalley GA; Bagg W; Doughty RN
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):109-25. PubMed ID: 18095911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncompaction of the ventricular myocardium mimicking ischemic cardiomyopathy.
    Matsumoto N; Sato Y; Kunimasa T; Matsuo S; Kato M; Yoda S; Suzuki Y; Tani S; Takahashi M; Saito S
    Ann Nucl Med; 2006 Nov; 20(9):639-41. PubMed ID: 17294676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of non-invasive imaging in the work-up of cardiomyopathies.
    Tummala LS; Young RK; Singh T; Jani S; Srichai MB
    Curr Atheroscler Rep; 2015 Mar; 17(3):486. PubMed ID: 25637041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine model of chronic ischemic cardiomyopathy: implications for ventricular assist device research.
    Bartoli CR; Sherwood LC; Giridharan GA; Slaughter MS; Wead WB; Prabhu SD; Koenig SC
    Artif Organs; 2013 Dec; 37(12):E202-14. PubMed ID: 23876076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Differential diagnosis of idiopathic cardiomyopathy from ischemic cardiomyopathy and hypertensive heart disease using non-invasive methods].
    Masuda Y
    Nihon Rinsho; 2000 Jan; 58(1):218-22. PubMed ID: 10885317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severely impaired left ventricular function: tissue characterization by cardiovascular magnetic resonance in a clinical dilemma.
    Bucciarelli-Ducci C; Locca D; O'Hanlon R; Oldershaw P; Prasad SK
    Eur J Heart Fail; 2007 Sep; 9(9):959-61. PubMed ID: 17609124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
    Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
    Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ischemic vs nonischemic heart failure--does etiology matter?].
    Follath F
    Ther Umsch; 2000 May; 57(5):321-3. PubMed ID: 10859992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late gadolinium enhancement from cardiac magnetic resonance in ischemic and non-ischemic cardiomyopathy.
    Krittayaphong R; Boonyasirinant T; Saiviroonporn P; Udompunturak S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S33-8. PubMed ID: 21721426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in Fabry cardiomyopathy between female and male patients: consequences for diagnostic assessment.
    Niemann M; Herrmann S; Hu K; Breunig F; Strotmann J; Beer M; Machann W; Voelker W; Ertl G; Wanner C; Weidemann F
    JACC Cardiovasc Imaging; 2011 Jun; 4(6):592-601. PubMed ID: 21679893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of ischemic from nonischemic cardiomyopathy during dobutamine stress by left ventricular long-axis function: additional effect of left bundle-branch block.
    Duncan AM; Francis DP; Gibson DG; Henein MY
    Circulation; 2003 Sep; 108(10):1214-20. PubMed ID: 12939221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Takotsubo cardiomyopathy.
    Chih S; McKeown B
    Intern Med J; 2007 Mar; 37(3):197-8. PubMed ID: 17316342
    [No Abstract]   [Full Text] [Related]  

  • 17. A predictive model for distinguishing ischemic from non-ischemic cardiomyopathy.
    Wongchareon W; Phrommintikul A; Kanjanavanit R; Kuanprasert S; Sukonthasarn A
    J Med Assoc Thai; 2005 Nov; 88(11):1689-96. PubMed ID: 16471120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.
    Briceno N; Schuster A; Lumley M; Perera D
    Heart; 2016 Mar; 102(5):397-406. PubMed ID: 26740480
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of ischemic and dilated cardiomyopathy on electrocardiograms.
    Aghasadeghi K; Aslani A
    Asian Cardiovasc Thorac Ann; 2008 Apr; 16(2):103-6. PubMed ID: 18381865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of three-dimensional echocardiographic findings to those of magnetic resonance imaging for determination of left ventricular mass in patients with ischemic and non-ischemic cardiomyopathy.
    Kusunose K; Kwon DH; Motoki H; Flamm SD; Marwick TH
    Am J Cardiol; 2013 Aug; 112(4):604-11. PubMed ID: 23768466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.